Concerta vs. Adderall: Comparing ADHD Treatments

Natalie Watkins
Dr. David Miles
Written by Natalie Watkins on 25 March 2025
Medically reviewed by Dr. David Miles on 17 April 2025

ADHD is a common neurological condition affecting between 2.5% and 4.4% of the adult population, with even higher rates seen in children. People with ADHD can struggle to pay attention, behave impulsively, and face obstacles in education and the workplace as well as at home.

There are three types of ADHD, based on the different symptoms displayed: inattentive type, hyperactive type, or combined. ADHD is commonly treated with stimulant medications, and approximately 75-92% of patients see improvements.

Two of the main medications used to treat ADHD are Concerta and Adderall. These medications are both stimulants, but they have slightly different effects. Here’s everything you need to know about both drugs and when you might want to choose one rather than the other.

Key takeaways:
  • ADHD is a neurodevelopmental disorder that can interfere with executive function but can be effectively treated with medication
  • Concerta and Adderall are two common drugs used to treat ADHD in both adults and children. There are few differences between them in terms of effectiveness and side effects
  • The best outcomes for ADHD are found when medications are combined with behavioral therapy to help patients learn new coping strategies
a photo of a blonde woman holding up a Concerta pill on one hand and an Adderall pill on the other

Understanding Concerta and Adderall

Both Concerta and Adderall are CNS stimulants, meaning that they increase the levels of norepinephrine and dopamine in the brain.

Concerta’s active ingredient is methylphenidate, which blocks norepinephrine and dopamine from being reabsorbed into cells and broken down. It is a slow-release medication.

Adderall uses a combination of amphetamines, known as mixed amphetamine salts (MAS). This includes 25% levoamphetamine and 75% dextroamphetamine. Adderall actively increases the amount of norepinephrine and dopamine released into the brain.

Concerta vs. Adderall: Key differences

The differences between Concerta and extended-release Adderall are minor. They are both slow-release medications, typically lasting approximately 8-12 hours. Adderall reaches maximum concentration within approximately 7 hours. For Concerta, this is around 4.7 hours.

Adderall is also available in an immediate-release format, which reaches peak concentration in 3-4 hours and typically lasts 4-6 hours. Similarly, methylphenidate, the active ingredient in Concerta, is available in an immediate-release form that reaches peak concentration in 1-2 hours and lasts around 3-4 hours.

Effectiveness comparison: Concerta vs. Adderall

Research into the effectiveness of Concerta vs. Adderall has had mixed results. Some studies have shown a small but consistent benefit for Adderall over Concerta. Others suggest that Concerta is better for improving visual memory and distractibility. Overall, there is little to choose between the two drugs in terms of effectiveness.

For most patients, choosing the right medication involves trial and adjustment in collaboration with a physician to find the best fit for their needs.

See also: Comparing Concerta vs. Vyvanse for ADHD Treatment

Side effects: Comparing risks and tolerability

The side effects of Concerta and Adderall are also relatively similar, including:

  • Decreased appetite
  • Dizziness
  • Insomnia
  • Nausea
  • Tachycardia and palpitations

For children, stimulants can reduce their growth by approximately 2cm if taken long-term.

Children taking Concerta appear to develop fewer side effects, which is why some (though not all) guidelines recommend offering this as the first-choice medication.

Potential for misuse

Both Adderall and Concerta are listed as Schedule II drugs, as a result of their potential for misuse and abuse. In extended-release forms, however, they are less likely to be misused than immediate-release versions. The immediate-release version of Adderall has greater potential for misuse.

Factors to consider when choosing between Concerta and Adderall

There is little evidence to help patients or doctors choose between Concerta and extended-release Adderall. Children should generally be offered Concerta before Adderall.

Some patients may prefer short-release Adderall, especially if they work shifts and need to be able to sleep at unexpected times of the day. Immediate-release medications can also be cheaper than extended-release versions.

Patients may respond better to one drug over the other and it is simple to switch between them.

Alternative treatments for ADHD

Although stimulants are the most common treatment for ADHD, alternative options are available.

Non-stimulant medication

Some non-stimulant medications have been shown to be effective in the treatment of ADHD and are licensed by the FDA for this use. These include tricyclic antidepressants, noradrenaline reuptake inhibitors such as atomoxetine, vasodilators including clonidine and guanfacine, and other antidepressants such as bupropion.

Behavioral interventions

Not all treatments for ADHD include taking medication. Behavioral interventions can teach a patient how to adapt to their condition and develop strategies to support them in everyday life. These interventions can be especially powerful for children, particularly when they include the parent, child, and school in the process.

Combination therapy

The best results for people with ADHD can often be found by combining medication with behavioral interventions.

FAQs

Common questions about Concerta vs. Adderall

Is Concerta stronger than Adderall?

Both Concerta and Adderall are highly effective at treating ADHD. There is no systematic difference in strength between the two. The more important factor is how well they work for an individual patient.

Are Concerta and Adderall equally effective for ADHD?

Overall, Concerta and Adderall are equally effective for the treatment of ADHD. They may not be equally effective for an individual patient, however. Some patients will respond better to Concerta while others will have a better experience with Adderall.

Can you take both Concerta and Adderall together?

Adderall and Concerta are both CNS stimulants that increase the levels of norepinephrine and dopamine in the brain. You should not take both drugs at the same time.

Which is more addictive: Concerta or Adderall?

Both Concerta and Adderall are Schedule II drugs, meaning that they are addictive and have the potential for abuse. There is little difference in addictiveness between the two substances. A significant factor for addiction to stimulants is how quickly they take effect, meaning that immediate-release Adderall may be more addictive than Concerta or extended-release Adderall.

Can you switch from Concerta to Adderall or vice versa?

Although Concerta and Adderall are very similar, some people will respond better to one of the two. If you do not have a good response to one of these drugs, for example, because it does not seem effective or it causes side effects, talk to your doctor about switching.

Was this page helpful?

Your feedback allows us to continually improve our information

Resources:

  1. Cortese, S., Adamo, N., Del Giovane, C., Mohr-Jensen, C., Hayes, A. J., Carucci, S., Atkinson, L. Z., Tessari, L., Banaschewski, T., Coghill, D., Hollis, C., Simonoff, E., Zuddas, A., Barbui, C., Purgato, M., Steinhausen, H.-C., Shokraneh, F., Xia, J., & Cipriani, A. (2018). Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: A systematic review and network meta-analysis. The Lancet Psychiatry, 5(9), 727–738.
  2. Goodman, D. W. (2010). Lisdexamfetamine Dimesylate (Vyvanse), A Prodrug Stimulant for Attention-Deficit/Hyperactivity Disorder. Pharmacy and Therapeutics, 35(5), 273.
  3. Wilson, H., Cox, D., Merkel, R., Moore, M., & Coghill, D. (2006). Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with Attention-Deficit/Hyperactivity Disorder. Archives of Clinical Neuropsychology, 21(8), 797–807.
  4. Milich, R. (2001). ADHD combined type and ADHD predominantly inattentive type are distinct and unrelated disorders. Clinical Psychology: Science and Practice, 8(4), 463–488.
  5. Verghese, C., & Abdijadid, S. (2023, January 2). Methylphenidate. Nih.gov; StatPearls Publishing.
  6. Martin, D., & Le, J. K. (2023, July 31). Amphetamine. PubMed; StatPearls Publishing.
  7. Faraone, S. V., Biederman, J., & Roe, C. (2002). Comparative efficacy of adderall and methylphenidate in attention-deficit/hyperactivity disorder: A meta-analysis. Journal of Clinical Psychopharmacology, 22(5), 468–473.
  8. Farzam, K., Faizy, R. M., & Saadabadi, A. (2023, July 2). Stimulants. PubMed; StatPearls Publishing.
  9. Hodgkins, P., Shaw, M., Coghill, D., & Hechtman, L. (2012). Amfetamine and methylphenidate medications for attention-deficit/hyperactivity disorder: Complementary treatment options. European Child & Adolescent Psychiatry, 21(9), 477–492.
  10. Nazila Sharbaf Shoar, Raman Marwaha, & Molla, M. (2019, December 26). Dextroamphetamine-Amphetamine. Nih.gov; StatPearls Publishing.
  11. Tulloch, S. J., Zhang, Y., McLean, A., & Wolf, K. N. (2002). SLI381 (Adderall XR), a two-component, extended-release formulation of mixed amphetamine salts: Bioavailability of three test formulations and comparison of fasted, fed, and sprinkled administration. Pharmacotherapy, 22(11), 1405–1415.
  12. Food and Drug Administration. (2007). Adderall® (CII) (medication guides attached) revised March 2007.
  13. National Institute for Health and Care Excellence. (2018, March 14). Attention deficit hyperactivity disorder: Diagnosis and management | guidance | NICE. Nice.org.uk; NICE.
  14. Bolea-Alamañac, B., Nutt, D. J., Adamou, M., Asherson, P., Bazire, S., Coghill, D., Heal, D., Müller, U., Nash, J., Santosh, P., Sayal, K., Sonuga-Barke, E., & Young, S. J. (2014). Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: Update on recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 28(3), 179–203.
  15. Weisler, R. H., & Childress, A. C. (2011). Treating attention-deficit/hyperactivity disorder in adults. The Primary Care Companion for CNS Disorders, 13(6).
  16. Elliott, J., Johnston, A., Husereau, D., Kelly, S. E., Eagles, C., Charach, A., Hsieh, S.-C., Bai, Z., Hossain, A., Skidmore, B., Tsakonas, E., Chojecki, D., Mamdani, M., & Wells, G. A. (2020). Pharmacologic treatment of attention deficit hyperactivity disorder in adults: A systematic review and network meta-analysis. PLOS ONE, 15(10), e0240584.
  17. Pliszka, S. R. (2003). Non-Stimulant treatment of attention-deficit/hyperactivity disorder. CNS Spectrums, 8(4), 253–258.
  18. Rajeh, A., Amanullah, S., Shivakumar, K., & Cole, J. (2017). Interventions in ADHD: A comparative review of stimulant medications and behavioral therapies. Asian Journal of Psychiatry, 25(25), 131–135.

Activity History - Last updated: 17 April 2025, Published date:


Reviewer

David is a seasoned Pharmacist, natural medicines expert, medical reviewer, and pastor. Earning his Doctorate from the Medical University of South Carolina, David received clinical training at several major hospital systems and has worked for various pharmacy chains over the years. His focus and passion has always been taking care of his patients by getting accurate information and thorough education to those who need it most. His motto: "Good Information = Good Outcomes".

Activity History - Medically Reviewed on 24 March 2025 and last checked on 17 April 2025

Medically reviewed by
Dr. David Miles

Dr. David Miles

PharmD

Reviewer

Recovered Branding BG
Ready to talk about treatment? Call today. (855) 648-7288
Helpline Information

Calls to numbers marked with (I) symbols will be answered or returned by one of the treatment providers listed in our Terms and Conditions, each of which is a paid advertiser.

In calling the helpline you agree to our Terms and Conditions. We do not receive any fee or commission dependent upon which treatment or provider a caller chooses.

There is no obligation to enter treatment.

Access State-Specific Provider Directories for detailed information on locating licensed service providers and recovery residences in your area.

For any specific questions please email us at info@recovered.org

More like this